SoftBank’s AI investments face increasing risks, especially in OpenAI and Stargate. Find out why SFTBF stock could be ...

SoftBank disclosed a 20.45M share position in PacBio (PACB) and 14.67M share position in Recursion Pharmaceuticals (RXRX) in a regulatory ...

The deal would exceed last year’s blockbuster share debut of subway operator Tokyo Metro, and be the largest since SoftBank’s ...

Artificial Intelligence (AI) has become an integral part of modern technology, revolutionizing industries with its ability to mimic human intelligence. At its core, AI enables machines to process vast ...

The Japanese investment holding company SoftBank Group ( OTCPK:SFTBY) purchased two new stakes: 20.45M shares in Pacific Biosciences of California ( PACB ), and 14.66M shares in Recursion ...

-- The chip is expected to be a central processing unit for large data-centre servers, and the chips' base can be customised for clients including Meta. Production will be outsourced to a manufacturer ...

Musk and his investor group submitted their bid to acquire OpenAI, which could have dramatically altered the AI industry’s ...

Meanwhile, Arm Holdings (NASDAQ:ARM) is making a bold moveditching its traditional licensing-only model to launch its own chips, with Meta (NASDAQ:META) already signed on as a key customer. The ...

The board of OpenAI unanimously rejected Elon Musk's $97.4 billion takeover bid, declaring on Friday that the tech firm is “not for sale.” Donald Trump’s “First Buddy” and a group of investment firms ...

India's quick-commerce industry, surged by Zomato and Swiggy, is deemed unsustainable in the long term, according to TVS ...

If that's indeed the case, then investors may have hit the panic button for the wrong reason. However, the good part is that Nvidia's poor start to the year means that investors have a window to buy ...